NAGE NIAGEN BIOSCIENCE INC
FollowCOM NEW (common), issuer CIK 1386570
Filings received so far for Q3 2026: 5 13F filers report a position in NAGE shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Silverberg Bernstein Capital Management… | 137,952 | $403K | 0.19% | -2,650 | 13F-HRTimeline |
| Miller Global Investments, LLC | 18,800 | $54.9K | 0.04% | 0 | 13F-HRTimeline |
| GAMMA Investing LLC | 2,017 | $5.89K | <0.01% | +1,659 | 13F-HRTimeline |
| AMERICAN NATIONAL BANK & TRUST | 1,784 | $5.21K | <0.01% | 0 | 13F-HRTimeline |
| Marquette Asset Management, LLC | 446 | $1.3K | <0.01% | new | 13F-HRTimeline |